NASDAQ:AKTS - Akoustis Technologies Stock Price, Forecast & News

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AKTS shares have decreased by 14.3% and is now trading at $4.55. View which stocks have been mosted impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Akoustis Technologies.

Akoustis Technologies is scheduled to release its next quarterly earnings announcement on Friday, May 8th 2020. View our earnings forecast for Akoustis Technologies.

Akoustis Technologies Inc (NASDAQ:AKTS) posted its earnings results on Monday, February, 3rd. The technology company reported ($0.30) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.26) by $0.04. The technology company earned $0.52 million during the quarter, compared to the consensus estimate of $0.55 million. Akoustis Technologies had a negative net margin of 1,791.55% and a negative return on equity of 98.09%. View Akoustis Technologies' earnings history.

4 equities research analysts have issued 12 month price objectives for Akoustis Technologies' stock. Their forecasts range from $7.00 to $12.00. On average, they expect Akoustis Technologies' share price to reach $10.00 in the next year. This suggests a possible upside of 119.8% from the stock's current price. View analysts' price targets for Akoustis Technologies.

News stories about AKTS stock have trended very negative this week, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Akoustis Technologies earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutAkoustis Technologies.

Some companies that are related to Akoustis Technologies include AudioCodes (AUDC), NetGear (NTGR), Telkom SA Ltd ADS (TLKGY), Plantronics (PLT), ADTRAN (ADTN), Clearfield (CLFD), DASAN Zhone Solutions (DZSI), Franklin Wireless (FKWL), Communications Systems (JCS), Zoom Technologies (ZOOM), Clearone (CLRO), AltiGen Communications (ATGN), Zoom Telephonics (ZMTP), Sonim Technologies (SONM) and Westell Technologies (WSTL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include NVIDIA (NVDA), Crispr Therapeutics (CRSP), Alibaba Group (BABA), Canopy Growth (CGC), Verizon Communications (VZ), Advanced Micro Devices (AMD), Editas Medicine (EDIT), Inovio Pharmaceuticals (INO), InVitae (NVTA) and Marvell Technology Group (MRVL).

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AKTS stock can currently be purchased for approximately $4.55.

Akoustis Technologies has a market capitalization of $164.76 million and generates $1.44 million in revenue each year. Akoustis Technologies employs 69 workers across the globe. View additional information about Akoustis Technologies.

The official website for Akoustis Technologies is http://www.akoustis.com/.

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at 704-997-5735 or via email at [email protected]